Itraconazole ITC (CAS NO : 84625-61-6)

Itraconazole is a triazole-class antifungal agent used to treat a variety of fungal infections by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes. Itraconazole or Oriconazole is effective against a broad spectrum of fungi, including Aspergillus, Blastomyces, Histoplasma, and Candida species. Manufacturers named Itraconazole as (Itrizole), which is also a member of the triazoles class, dioxolane, N-arylpiperazine, dichlorobenzene, cyclic ketal, and aromatic ether. Derived from cis-ketoconazole, Itraconazole's imidazol-1-yl group is replaced by a 1,2,4-triazol-1-yl group, and the acetyl group on the piperazine moiety is substituted by a p-[(±)1-sec-butyl-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]phenyl group. ECHA deprecated cas number is 84604-65-9 for Itraconazole. Itraconazole is specifically FDA Approved and is in WHO Essential Medicines List. We are the trusted Itraconazole supplier worldwide with reliable lead times and global supply capability.